Carotid atherosclerosis: is it treatable?

J Chin Med Assoc. 2005 Feb;68(2):49-50. doi: 10.1016/S1726-4901(09)70133-9.

Abstract

The assessment of brachial-artery FMD is a reliable, reproducible and noninvasive tool for evaluating endothelial dysfunction, which, together with endothelial inflammation, causes carotid atherosclerosis. Atorvastatin therapy can reverse endothelial dysfunction after 4 months, and may have significant anti-inflammatory effects if continued for more than 4 months. Importantly, statin therapy can be used to treat carotid atherosclerosis.

Publication types

  • Comment
  • Editorial

MeSH terms

  • Carotid Artery Diseases / drug therapy*
  • Carotid Artery, Common / drug effects
  • Carotid Artery, Common / pathology
  • Carotid Artery, Internal / drug effects
  • Carotid Artery, Internal / pathology
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
  • Myocardial Infarction / prevention & control

Substances

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors